D2C route to market for DTx

Health-related Google searches are increasing year after year, showing that consumers are interested in knowing more about their health conditions and how to manage them. This might pose D2C as a reasonable market strategy for some DTx products, especially for those early-stage companies as it can help them gain traction faster and generate Real-World Data to show to other stakeholders (e.g. pharma, payers, etc). But when is D2C the right route to market? What are the challenges to make it work? Join this meeting to have an informal conversation with other senior leaders about: